{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:02:09Z","timestamp":1789340529435,"version":"build-2803163510"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sarcoidosis is a chronic granulomatous disorder characterized by unknown etiology, undetermined mechanisms, and non-specific therapies except TNF blockade. To improve our understanding of the pathogenicity and to predict the outcomes of the disease, the identification of new biomarkers and molecular endotypes is sorely needed. In this study, we systematically evaluate the biomarkers identified through Omics and non-Omics approaches in sarcoidosis. Most of the currently documented biomarkers for sarcoidosis are mainly identified through conventional \u201cone-for-all\u201d non-Omics targeted studies. Although the application of machine learning algorithms to identify biomarkers and endotypes from unbiased comprehensive Omics studies is still in its infancy, a series of biomarkers, overwhelmingly for diagnosis to differentiate sarcoidosis from healthy controls have been reported. In view of the fact that current biomarker profiles in sarcoidosis are scarce, fragmented and mostly not validated, there is an urgent need to identify novel sarcoidosis biomarkers and molecular endotypes using more advanced Omics approaches to facilitate disease diagnosis and prognosis, resolve disease heterogeneity, and facilitate personalized medicine.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1342429","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:21:22Z","timestamp":1704342082000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies"],"prefix":"10.3389","volume":"14","author":[{"given":"Hong-Long","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Mile S.","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan G.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun Sophia","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Gahtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2023.2183193","article-title":"An expert overview of pulmonary fibrosis in sarcoidosis","volume":"17","author":"Gupta","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201303-069FR","article-title":"Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes","volume":"10","author":"Patterson","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: A review","volume":"327","author":"Belperio","year":"2022","journal-title":"Jama"},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12931-022-01993-z","article-title":"Clinical phenotyping in sarcoidosis using cluster analysis","volume":"23","author":"Lin","year":"2022","journal-title":"Respir Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.06.001","article-title":"Identification of multidimensional phenotypes using cluster analysis in sarcoid uveitis patients","volume":"242","author":"Fermon","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00608-5","article-title":"BAL biomarkers\u2019 panel for differential diagnosis of interstitial lung diseases","volume":"20","author":"d\u2019Alessandro","year":"2020","journal-title":"Clin Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2002950","DOI":"10.1183\/13993003.02950-2020","article-title":"Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis","volume":"58","author":"Vukmirovic","year":"2021","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1744666X.2019.1568240","article-title":"Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis","volume":"15","author":"Ramos-Casals","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000403","article-title":"Transcriptome profiles in sarcoidosis and their potential role in disease prediction","volume":"23","author":"Schupp","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"104394","DOI":"10.1016\/j.ebiom.2022.104394","article-title":"Sepsis biomarkers and diagnostic tools with a focus on machine learning","volume":"86","author":"Komorowski","year":"2022","journal-title":"EBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"104947","DOI":"10.1016\/j.compbiomed.2021.104947","article-title":"A review on omics-based biomarkers discovery for Alzheimer\u2019s disease from the bioinformatics perspectives: Statistical approach vs machine learning approach","volume":"139","author":"Tan","year":"2021","journal-title":"Comput Biol Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8565423","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic biomarkers of sarcoidosis: A comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6","volume":"2019","author":"Bergantini","year":"2019","journal-title":"Dis Markers."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000306","article-title":"Biomarkers in sarcoidosis: the contribution of system biology","volume":"22","author":"Carleo","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2015.08.005","article-title":"Identifying novel biomarkers in sarcoidosis using genome-based approaches","volume":"36","author":"Casanova","year":"2015","journal-title":"Clin Chest Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1012827","article-title":"Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2","volume":"9","author":"Casanova","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13635","article-title":"Adaptive immune system in pulmonary sarcoidosis-Comparison of peripheral and alveolar biomarkers","volume":"205","author":"d\u2019Alessandro","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxac009","article-title":"Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles","volume":"34","author":"Futami","year":"2022","journal-title":"Int Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"106390","DOI":"10.1016\/j.rmed.2021.106390","article-title":"Genomic biomarkers in chronic beryllium disease and sarcoidosis","volume":"187","author":"Lin","year":"2021","journal-title":"Respir Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-012-0585-9","article-title":"Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers","volume":"62","author":"Paone","year":"2013","journal-title":"Inflammation Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2006.26.400","article-title":"Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis","volume":"26","author":"Antoniou","year":"2006","journal-title":"J Interferon Cytokine Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200803-490OC","article-title":"Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis","volume":"179","author":"Crouser","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-009-0756-6","article-title":"Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis","volume":"54","author":"Kitaichi","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121072109","article-title":"Common patterns and disease-related signatures in tuberculosis and sarcoidosis","volume":"109","author":"Maertzdorf","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B30","article-title":"Bronchoalveolar lavage chitotriosidase activity as a biomarker of sarcoidosis","volume":"32","author":"Harlander","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161669","article-title":"Expression profile of six RNA-binding proteins in pulmonary sarcoidosis","volume":"11","author":"Navratilova","year":"2016","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"107039","DOI":"10.1016\/j.rmed.2022.107039","article-title":"Analysis of lymphocyte profile in lymph nodes, bronchoalveolar lavage fluid and peripheral blood in patients with stage II sarcoidosis","volume":"205","author":"Mi","year":"2022","journal-title":"Respir Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.3390\/ijms24044071","article-title":"The effects of interstitial lung diseases on alveolar extracellular vesicles profile: A multicenter study","volume":"24","author":"d\u2019Alessandro","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"120668","DOI":"10.1016\/j.jns.2023.120668","article-title":"Cerebrospinal fluid B-cell activating factor levels as a novel biomarker in patients with neurosarcoidosis","volume":"449","author":"Sumi","year":"2023","journal-title":"J Neurol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12931-019-1263-z","article-title":"Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis","volume":"21","author":"Bennett","year":"2020","journal-title":"Respir Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000196564","article-title":"Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis","volume":"63","author":"Ma\u00f1\u00e1","year":"1996","journal-title":"Respiration"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00028209","article-title":"Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis","volume":"34","author":"Beirne","year":"2009","journal-title":"Eur Respir J"},{"key":"B39","first-page":"27","article-title":"Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis","volume":"27","author":"Handa","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9754-4","article-title":"Human chitotriosidase: a sensitive biomarker of sarcoidosis","volume":"33","author":"Bargagli","year":"2013","journal-title":"J Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.04.144","article-title":"Urinary 8-hydroxy-2\u2019-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis","volume":"190","author":"Kobayashi","year":"2015","journal-title":"Int J Cardiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.03.003","article-title":"An oxidative stress biomarker, urinary 8-hydroxy-2\u2019-deoxyguanosine, predicts cardiovascular-related death after steroid therapy for patients with active cardiac sarcoidosis","volume":"212","author":"Myoren","year":"2016","journal-title":"Int J Cardiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.006764","article-title":"Urinary 8-hydroxy-2\u2019-deoxyguanosine as a myocardial oxidative stress marker is associated with ventricular tachycardia in patients with active cardiac sarcoidosis","volume":"10","author":"Ishiguchi","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13792","article-title":"Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement","volume":"44","author":"Thi Hong Nguyen","year":"2017","journal-title":"J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A multiple biomarker approach in patients with cardiac sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/biom8030084","article-title":"YKL-40, soluble IL-2 receptor, angiotensin converting enzyme and C-reactive protein: comparison of markers of sarcoidosis activity","volume":"8","author":"Uysal","year":"2018","journal-title":"Biomolecules"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000725","article-title":"Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis","volume":"7","author":"Otto","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.36141\/svdld.v37i1.8313","article-title":"Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis","volume":"37","author":"Miyata","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2020.1751614","article-title":"Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis","volume":"14","author":"Schimmelpennink","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09158-0","article-title":"Utility of serological biomarker\u2019 panels for diagnostic accuracy of interstitial lung diseases","volume":"68","author":"Bergantini","year":"2020","journal-title":"Immunol Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13023-021-01926-x","article-title":"Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis","volume":"16","author":"Horimasu","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274381","article-title":"Autoantibody profile in sarcoidosis, analysis from the GRADS sarcoidosis cohort","volume":"17","author":"Khassawneh","year":"2022","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v36i2.7620","article-title":"Cathepsin S, a new serum biomarker of sarcoidosis discovered by transcriptome analysis of alveolar macrophages","volume":"36","author":"Tanaka","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42003-020-01318-0","article-title":"Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis","volume":"3","author":"Chai","year":"2020","journal-title":"Commun Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.03.002","article-title":"Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum","volume":"101","author":"Bons","year":"2007","journal-title":"Respir Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1465-9921-14-18","article-title":"Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients","volume":"14","author":"Zhang","year":"2013","journal-title":"Respir Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201407-1341OC","article-title":"Proteomic profiling reveals autoimmune targets in sarcoidosis","volume":"191","author":"H\u00e4ggmark","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B58","article-title":"Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis","volume":"33","author":"Duchemann","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B59","first-page":"29","article-title":"Plasma metabolomic profile in fibrosing pulmonary sarcoidosis","volume":"33","author":"Mirsaeidi","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"19584","DOI":"10.1038\/s41598-019-56174-8","article-title":"Metabolomic and metallomic profile differences between Veterans and Civilians with Pulmonary Sarcoidosis","volume":"9","author":"Banoei","year":"2019","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaut.2018.07.012","article-title":"Molecular profiling of regulatory T cells in pulmonary sarcoidosis","volume":"94","author":"Kachamakova-Trojanowska","year":"2018","journal-title":"J Autoimmun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13153","article-title":"mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis","volume":"49","author":"Papli\u0144ska-Goryca","year":"2019","journal-title":"Eur J Clin Invest."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.320449","article-title":"Transcriptional and immune landscape of cardiac sarcoidosis","volume":"131","author":"Liu","year":"2022","journal-title":"Circ Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00178111","article-title":"Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis","volume":"41","author":"Silva","year":"2013","journal-title":"Eur Respir J"},{"key":"B65","first-page":"17","article-title":"Alterations in the membrane-associated proteome fraction of alveolar macrophages in sarcoidosis","volume":"33","author":"Kjellin","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/ijms20092157","article-title":"SpotLight proteomics-A igG-enrichment phenotype profiling approach with clinical implications","volume":"20","author":"Lundstr\u00f6m","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/s41598-021-84815-4","article-title":"The effects of exercise training on lipid profile in patients with sarcoidosis","volume":"11","author":"Jastrzebski","year":"2021","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1038\/s41598-021-83524-2","article-title":"Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures","volume":"11","author":"Gupta","year":"2021","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3390\/jcm9082633","article-title":"Current insights in genetics of sarcoidosis: functional and clinical impacts","volume":"9","author":"Calender","year":"2020","journal-title":"J Clin Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000719","article-title":"Recent advances in sarcoidosis genomics: epigenetics, gene expression, and gene by environment (G\u200a\u00d7\u200aE) interaction studies","volume":"26","author":"Garman","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000716","article-title":"Molecular profiling in sarcoidosis","volume":"26","author":"Arger","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s13665-022-00298-2","article-title":"Management of sarcoidosis: when to treat, how to treat and for how long","volume":"11","author":"Fraser","year":"2022","journal-title":"Curr Pulmonology Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056841","article-title":"Defining CD4 T helper and T regulatory cell endotypes of progressive and remitting pulmonary sarcoidosis (BRITE): protocol for a US-based, multicentre, longitudinal observational bronchoscopy study","volume":"11","author":"Koth","year":"2021","journal-title":"BMJ Open"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1342429\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:21:30Z","timestamp":1704342090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1342429\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2023.1342429"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1342429","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"article-number":"1342429"}}